Trial Profile
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma: Symbicort SMART, or Other ICS/LABA With as Needed SABA.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2012
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Beta-adrenergic receptor agonists; Corticosteroids
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 23 Feb 2012 Actual patient number is 842 according to ClinicalTrials.gov.
- 23 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.